biotechnology news, page-5

Its the high level of fulse positives that has the doctors concerned . The newer test will address that somewhat.

Interesting only 150 tests done in the last 20 months no wonder they have been quiet about sales.
be interesting to see how tests have been going in the UK

Its a good trading stock but current price is too high given the negative publicity IMHO and lack of sales (probably be even less sales now)